Covers a new acid-resistant covalent organic framework that co-delivers antibiotic and anti-biofilm drugs for local osteomyelitis therapy and bone recovery.
Key Takeaways
- Please note there may be errors present which affect the content, and all legal disclaimers apply
- We develop an acid-resistant amine-linked heteroporous covalent organic framework (ARCOF)
- Therapeutic efficacy is evaluated in a rat PTO model